Carregando...
Gaps in Ambulatory Patient Safety for Immunosuppressive Specialty Medications
OBJECTIVES: With new specialty drugs such as biologics available in record numbers, people with immune-mediated diseases face increasing safety risks. However, comprehensive assessments of patient safety for these new specialty drugs are lacking. We examined performance on key patient safety measure...
Na minha lista:
| Publicado no: | Jt Comm J Qual Patient Saf |
|---|---|
| Principais autores: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7433663/ https://ncbi.nlm.nih.gov/pubmed/30686706 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcjq.2018.12.003 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|